UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immuno-oncology: understanding the function and dysfunction of the immune system in cancer

Annals of oncology, 2012-09, Vol.23 Suppl 8 (Suppl 8), p.viii6-viii9

Finn, O J

2012

Volltextzugriff (PDF)

Cancer vaccines: between the idea and the reality

Nature reviews. Immunology, 2003-08, Vol.3 (8), p.630-641

Finn, Olivera J

2003

Volltextzugriff (PDF)

T-cell death and cancer immune tolerance

Cell death and differentiation, 2008-01, Vol.15 (1), p.70-79

2008

Volltextzugriff (PDF)

Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients

Cancer research (Chicago, Ill.), 2001-06, Vol.61 (12), p.4756-4760

2001

Volltextzugriff (PDF)

The Mechanism of Unresponsiveness to Circulating Tumor Antigen MUC1 Is a Block in Intracellular Sorting and Processing by Dendritic Cells

The Journal of immunology (1950), 2000-10, Vol.165 (7), p.3730-3741

2000

Volltextzugriff (PDF)

Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients

Cancer research (Chicago, Ill.), 1994-06, Vol.54 (11), p.2856-2860

1994

Volltextzugriff (PDF)

Specific, Major Histocompatibility Complex-Unrestricted Recognition of Tumor-Associated Mucins by Human Cytotoxic T Cells

Proceedings of the National Academy of Sciences - PNAS, 1989-09, Vol.86 (18), p.7159-7163

1989

Volltextzugriff (PDF)

A Phase I Trial of a Synthetic Mucin Peptide Vaccine: Induction of Specific Immune Reactivity in Patients with Adenocarcinoma

The Journal of surgical research, 1996-06, Vol.63 (1), p.298-304

1996

Volltextzugriff (PDF)

Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells

Cancer research (Chicago, Ill.), 1998-11, Vol.58 (22), p.5066-5070

1998

Volltextzugriff (PDF)

Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA

The Journal of immunology (1950), 1993-08, Vol.151 (3), p.1654-1662

1993

Volltextzugriff (PDF)

Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1)

Cancer research (Chicago, Ill.), 1996-08, Vol.56 (16), p.3763-3770

1996

Volltextzugriff (PDF)

Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer

Cancer Immunology, Immunotherapy, 2005-03, Vol.54 (3), p.254-264

2005

Volltextzugriff (PDF)

MUC1 Immunobiology: From Discovery to Clinical Applications

Advances in Immunology, 2004, Vol.82, p.249-293

2004

Volltextzugriff (PDF)

Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells

The Journal of experimental medicine, 2002-12, Vol.196 (11), p.1435-1446

2002

Volltextzugriff (PDF)

Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses

Clinical cancer research, 1999-07, Vol.5 (7), p.1918-1924

1999

Volltextzugriff (PDF)

Three Different Vaccines Based on the 140-Amino Acid MUC1 Peptide with Seven Tandemly Repeated Tumor-Specific Epitopes Elicit Distinct Immune Effector Mechanisms in Wild-Type Versus MUC1-Transgenic Mice with Different Potential for Tumor Rejection

The Journal of immunology (1950), 2001-06, Vol.166 (11), p.6555-6563

2001

Volltextzugriff (PDF)

Induction of Cellular Immunity in Chimpanzees to Human Tumor-Associated Antigen Mucin by Vaccination with MUC-1 cDNA-Transfected Epstein-Barr Virus-Immortalized Autologous B Cells

Proceedings of the National Academy of Sciences - PNAS, 1996-02, Vol.93 (4), p.1699-1704

1996

Volltextzugriff (PDF)

Prophylactic cancer vaccines

Current Opinion in Immunology, 2002-04, Vol.14 (2), p.172-177

2002

Volltextzugriff (PDF)

PCR-based analysis of the T-cell receptor V beta multigene family: experimental parameters affecting its validity

BioTechniques, 1992-08, Vol.13 (2), p.248

1992

Volltextzugriff (PDF)

Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells

The Journal of experimental medicine, 2001-11, Vol.194 (9), p.1313-1324

2001

Volltextzugriff (PDF)

Beneficial autoimmunity improves cancer prognosis

Nature reviews. Clinical oncology, 2021-09, Vol.18 (9), p.591-602

2021

Volltextzugriff (PDF)

DNA vaccines for cancer too

Cancer Immunology, Immunotherapy, 2006-02, Vol.55 (2), p.119-130

2006

Volltextzugriff (PDF)

Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53

Molecular immunology, 2002-05, Vol.38 (12), p.981-987

2002

Volltextzugriff (PDF)

Immuno-oncology: understanding the function and dysfunction of the immune system in cancer: Advances in Immuno-oncology

Annals of oncology, 2012, Vol.23

FINN, O. J

2012

Volltextzugriff (PDF)

T cell receptor beta-chain selection in human allograft rejection

The Journal of immunology (1950), 1989-01, Vol.142 (1), p.81-86

1989

Volltextzugriff (PDF)

1 – 25 von 945

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(835)
Mit Volltextzugriff
(761)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(630)
Life Sciences & Biomedicine
(548)
Humans
(444)
Biological And Medical Sciences
(241)
Male
(227)
Female
(216)
Medical Sciences
(187)
Animals
(152)
Adult
(140)
Middle Aged
(131)
Aged
(101)
Immunology
(82)
Oncology
(74)
Physical Sciences
(70)
Medicin Och Hälsovetenskap
(69)
Mice
(67)
Biochemistry & Molecular Biology
(64)
Fundamental And Applied Biological Sciences. Psychology
(63)
Molecular Sequence Data
(60)
Amino Acid Sequence
(51)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Immuno-oncology: understanding the function and dysfunction of the immune system in cancer

Cancer vaccines: between the idea and the reality

T-cell death and cancer immune tolerance

Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients

The Mechanism of Unresponsiveness to Circulating Tumor Antigen MUC1 Is a Block in Intracellular Sorting and Processing by Dendritic Cells

Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients

Specific, Major Histocompatibility Complex-Unrestricted Recognition of Tumor-Associated Mucins by Human Cytotoxic T Cells

A Phase I Trial of a Synthetic Mucin Peptide Vaccine: Induction of Specific Immune Reactivity in Patients with Adenocarcinoma

Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells

Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA

Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1)

Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer

MUC1 Immunobiology: From Discovery to Clinical Applications

Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells

Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses

Three Different Vaccines Based on the 140-Amino Acid MUC1 Peptide with Seven Tandemly Repeated Tumor-Specific Epitopes Elicit Distinct Immune Effector Mechanisms in Wild-Type Versus MUC1-Transgenic Mice with Different Potential for Tumor Rejection

Induction of Cellular Immunity in Chimpanzees to Human Tumor-Associated Antigen Mucin by Vaccination with MUC-1 cDNA-Transfected Epstein-Barr Virus-Immortalized Autologous B Cells

Prophylactic cancer vaccines

PCR-based analysis of the T-cell receptor V beta multigene family: experimental parameters affecting its validity

Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells

Beneficial autoimmunity improves cancer prognosis

DNA vaccines for cancer too

Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53

Immuno-oncology: understanding the function and dysfunction of the immune system in cancer: Advances in Immuno-oncology

T cell receptor beta-chain selection in human allograft rejection

Suchergebnisse filtern